Historically, September has been one of the weakest months for the S&P 500. Here’s how to cope with this seasonal slump. Read More
Analyst Articles
Here’s a look at the most common business mistakes made by cannabis companies and how smart weed entrepreneurs are learning to avoid them. Read More
Decelerating labor market growth has made some observers nervous, but keep your perspective. The economy is far from imploding. Read More
Our editorial director answers the latest batch of emails from readers, with advice of universal applicability for individual investors. Read More
Here’s how to position your portfolio ahead of the FOMC's likely decision this month to reduce interest rates. Read More
Opportunities are plentiful in the cannabis sector, but so are predators. Looking to buy pot stocks? Here's how to avoid getting slaughtered. Read More
Worries about energy demand destruction have hit oil prices, which hurts energy equities but curbs inflation ahead of the next FOMC meet. Read More
Although a double-edged sword for the marijuana industry as a whole, the trend of increasingly high THC levels in weed is being leveraged as an advantage by portfolio pick Organigram. Read More
Although equities started September with a sharp drop, the bull market rally finished the month of August in robust shape. Read More
Cannabis is increasingly more potent and that could pose a public health risk, as well as an impediment to weed’s social acceptance. Read More